An extension trial revealed that long-term anifrolumab treatment improved health status and health-related quality of life in ...

Mean pre- and 2-year post-treatment patient-reported outcomes version of the Common Terminology Criteria for Adverse Events scores (0 to 4 scale, higher worse) were as follows: swallowing, 0.5/0.7, ...